Innocean Selected SGBio as Final Acquisition Candidate
Innosis announced on the 10th that Sigibiotech has been selected as the final preferred bidder for the public sale.
Earlier, on July 28, Innosis conducted a public sale using the stalking horse method and on September 13, selected the MDS consortium as the preferred negotiation party.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- Despite Warnings of "Do Not Enter, You May Not Make It Out Alive"... Foreign Tourist Stranded After Unauthorized Climb on Jeju Sanbangsan
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
The company stated, "Since the MDS consortium did not exercise its preemptive purchase right by 4 PM on the 10th, the deadline for exercising the right, it is considered to have waived the preemptive right," and added, "Sigibiotech Co., Ltd., the highest scorer in the public competitive bidding, has been selected as the final preferred bidder."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
